SCHD vs VHT
Schwab US Dividend Equity ETF vs Vanguard Health Care ETF
- • SCHD has the lower expense ratio at 0.06% vs 0.09% for VHT.
- • SCHD pays a higher dividend yield (2.95%).
Side-by-side metrics
| Metric | SCHD | VHT |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.06% | 0.09% |
Dividend yield Trailing 12-month yield. | 2.95% | 1.35% |
AUM Assets under management — bigger funds are typically more liquid. | $121.09B | $23.73B |
YTD return | 33.16% | 22.17% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.49 | 0.46 |
P/E ratio | 19.30 | 32.41 |
Last price | $35.88 | $347.68 |
Inception | — | — |
Issuer | Schwab | Vanguard |
SCHD top holdings
| TXN | Texas Instruments Inc | 4.58% |
| COP | ConocoPhillips | 4.35% |
| CVX | Chevron Corp | 4.31% |
| PG | Procter & Gamble Co | 4.24% |
| KO | Coca-Cola Co | 4.13% |
| AMGN | Amgen Inc | 4.08% |
| HD | The Home Depot Inc | 4.01% |
| UNH | UnitedHealth Group Inc | 3.95% |
| MRK | Merck & Co Inc | 3.82% |
| PEP | PepsiCo Inc | 3.79% |
VHT top holdings
| LLY | Eli Lilly and Co | 12.93% |
| JNJ | Johnson & Johnson | 8.78% |
| ABBV | AbbVie Inc | 6.45% |
| MRK | Merck & Co Inc | 5.01% |
| UNH | UnitedHealth Group Inc | 4.65% |
| TMO | Thermo Fisher Scientific Inc | 3.50% |
| AMGN | Amgen Inc | 3.18% |
| GILD | Gilead Sciences Inc | 2.58% |
| ABT | Abbott Laboratories | 2.40% |
| PFE | Pfizer Inc | 2.27% |
About SCHD
SCHD (Schwab US Dividend Equity ETF) is High-quality US dividend-paying stocks. Managed by Schwab, the fund carries $121.1B in assets under management, an expense ratio of 0.06%, a dividend yield of 2.95%. Its largest holding is Texas Instruments Inc (TXN), which represents 4.6% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 6.8%.
About VHT
VHT (Vanguard Health Care ETF) is US health care sector stocks. Managed by Vanguard, the fund carries $23.7B in assets under management, an expense ratio of 0.09%, a dividend yield of 1.35%. Its largest holding is Eli Lilly and Co (LLY), which represents 12.9% of the portfolio. Technology is the fund's largest sector exposure at 0.0%.